Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for UV Flu Technologies's Debt-to-EBITDA or its related term are showing as below:
UVFT's Debt-to-EBITDA is not ranked *
in the Industrial Products industry.
Industry Median: 1.695 * Ranked among companies with meaningful Debt-to-EBITDA only.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
UV Flu Technologies Debt-to-EBITDA Related Terms
UV Flu Technologies Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for UV Flu Technologies's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UVFT vs PCTL, DSOX, CDTI: Debt-to-EBITDA Comparison
For the Pollution & Treatment Controls subindustry, UV Flu Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UV Flu Technologies Debt-to-EBITDA vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, UV Flu Technologies's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where UV Flu Technologies's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2016) EBITDA data.
UV Flu Technologies (UVFT) has a Debt-to-EBITDA of -0.71 as of Mar. 2016. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on UV Flu Technologies.
Is UV Flu Technologies' Debt-to-EBITDA too high?
UV Flu Technologies' current Debt-to-EBITDA is -0.71.
How does UV Flu Technologies' Debt-to-EBITDA compare to PCTL and DSOX?
UV Flu Technologies' Debt-to-EBITDA of -0.71 can be compared against companies in the Industrial Products industry. The industry median Debt-to-EBITDA is 1.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for an Industrial Products company?
The median Debt-to-EBITDA among Industrial Products companies is 1.70, based on 2,332 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on UV Flu Technologies. For the Industrial Products industry, the median Debt-to-EBITDA is 1.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UV Flu Technologies's current Debt-to-EBITDA is -0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UV Flu Technologies stock overvalued right now?
UV Flu Technologies (UVFT) has a current Debt-to-EBITDA of -0.71. The current Debt-to-EBITDA is -0.71. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For UV Flu Technologies (UVFT), the current Debt-to-EBITDA is -0.71 as of Mar. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
UV Flu Technologies Inc is a manufacturer of the finest air purification systems. In addition, it also acts as a developer, manufacturer, and distributor of biotechnology products targeting the rapidly growing Indoor Air Quality industry sector. The company's flagship product is the ViraTech-RX-400 model which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that goes beyond filtering to destroy harmful bacteria. All of UV Flu's products are manufactured in the United States of America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UVFT has been successfully added to your 
